The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
"This stock is unavailable to buy. You can continue to hold existing shares and sell as usual, but you cannot buy anymore."
possibly a pedantic musing but using the term 'anymore' above makes it sound like you wouldn't be able to buy in the future, I think what they really mean is 'any more'
Dodged a bullet as I almost bought back in at 60 but "Cash collection has improved post year end and as at 10 November 2022 we have realised approximately £5.7m or 91% of our year end debtor book"
I guess this helps pay the increased dividend (£300k ?), but I wasnt immediately sure that paying a dividend was a smart move at first glance
you have to see it in the context of a 30% rise since early October, many big buyers are going to take profits knowing there is going to be a sell on news. Even I sold my traders yesterday as I foresaw what was likely to happen, wait a few days as there may be more pain to come as some get disillusioned
shareholders normally the last to know, could they be having a contract difficulties ? not invested here currently but always keeping a watch
based on previous record...... for "we" read 'they', for "mitigate" read 'devastate', for "accelerated receipt in recompense" read 'we've been fired'
"Regarding our Ghana port operations, whilst we remain on site and continue to operate as normal, the relationship with our local partners, Scanport, has become increasingly strained in recent months. We are looking at potential mediation to resolve matters, but we may look to terminate the arrangement early, in 2023, rather than 2024 and receive accelerated receipt in recompense accordingly. This would allow us to free up resources for the new and larger managed services projects we expect to have in place by 2023 which will mitigate any impact on our 2023 expectations"
come on Pete spit it out and don't beat about the bush ffs, it's 'significantly below market expectations'
"The Board's current expectation is that 2022 revenue outturn will be approximately a third below market expectations, which is expected to deliver a loss before tax equivalent to approximately half of that reported in 2021"
From 'The Other Side'
"Net current assets to 31 Mar 22 were about £2.3m and to 30 Sep 21 were 2.6m. The claim that there is nearly £2m left indicates £300k has gone in 6 months, so about £50k a month is trickling out. This is not just employee (BoD) salaries but also all the advisors and other leaches. There are probably more leaches still to feed before relisting finally occurs."
This is a **** show and we are all being led up the garden path & it stinks bod, nothing but an imminent listing (within a week) will appease me personally
I already did fortunately over 1p, shame it was in profit at 1.5, always keeping a lookout though for a reopportunity, mindful of someone saying there might be a trading update due early Nov tho, share falling in advance looks like a red flag
looks like it's driven you to drink already
what a crock of bull****, I smell a rat
feels like a background seller here, Science Group ?